Last Round
Series A
Extension
Feb 25, 2025
Est. Valuation
$49.8M
Total Funding Raised
$33.62M
Company Overview
BobcatBio is a biotechnology company that develops cancer-specific immunotherapy for the treatment of solid tumors. The company's adoptive cell therapy approach is designed to elicit a polyclonal immune response against multiple tumor antigens.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BobcatBio Comps
Public and private peers based on sector, stage, and business model.
BobcatBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 25, 2025 | ||||
| Seed | Sep 29, 2021 | ||||
| Series A | Jul 23, 2021 |
BobcatBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Life Sciences Greenhouse Investments | Series A |
| GRA Venture Fund | Series A |
| SeedFolio | Series A |
| BioAdvance Capital | Seed, Series A, Series A Extension |
| Vision Seed Capital | Seed |
| Bios Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 25, 2025
$7M round led by BioAdvance Capital
- Sep 29, 2021
$115K round from BioAdvance Capital and Vision Seed Capital.
BobcatBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BobcatBio's valuation, stock price, and market status.
